Wellstox 100 – Korean Botulinum Toxin Type A for Aesthetic and Therapeutic Precision
1. Overview & Manufacturer
Wellstox 100 is a botulinum toxin type A injectable product developed in South Korea, created to meet the growing demand for safe, high-purity, and cost-effective neuromodulators in the global aesthetic and therapeutic markets. Manufactured under GMP-compliant standards, Wellstox is formulated to offer consistent clinical results for both facial rejuvenation and selected therapeutic treatments.2. Composition & Packaging
Each vial contains 100 units of Clostridium botulinum toxin type A, supplied as a lyophilized (freeze-dried) powder
Requires reconstitution with 0.9% sterile saline (NaCl) before administration
Features a high-purity, low-protein formula, reducing the risk of antibody formation and treatment resistance over time
3. Mechanism of Action
Wellstox works by blocking the release of acetylcholine at the neuromuscular junction, resulting in temporary muscle relaxation. This mechanism allows:
Reduction of dynamic wrinkles
Facial slimming and contouring
Control of overactive muscles or sweat glands
Symptom relief for muscle-related therapeutic conditions
4. Key Advantages
Consistent onset: Visible effects usually begin within 2–4 days
Long-lasting results: Typically 3–6 months, depending on the patient and treatment area
Smooth and even diffusion: Delivers natural-looking results with controlled precision
Cost-effective: High-quality alternative to premium brands like Botox®, Dysport®, and Xeomin®
Ideal for global markets: Manufactured under international pharmaceutical standards
5. Common Clinical Applications
Aesthetic Uses:
Glabellar lines (frown lines)
Forehead wrinkles
Crow’s feet (around the eyes)
Bunny lines (nasal wrinkles)
Chin dimpling and lip asymmetry
Masseter muscle hypertrophy (jawline slimming)
Platysmal bands (neck tightening)
Therapeutic (Off-label) Uses:
Axillary, palmar, or plantar hyperhidrosis (excessive sweating)
Bruxism and TMJ disorders
Chronic migraines
Localized muscle spasticity or twitching
6. Suggested Dosage Guidelines
| Treatment Area | Units (U) |
|---|---|
| Glabella | 10–20 |
| Forehead | 8–15 |
| Crow’s feet (per side) | 6–12 |
| Masseter (per side) | 25–40 |
| Axillary sweating | 50 per axilla |
Note: Dosing should be customized based on the patient’s needs and anatomy.
7. Storage & Handling
Store between 2–8°C (refrigerated); do not freeze
Reconstitute with 2.0–2.5 mL sterile saline for a concentration of 4–5 U per 0.1 mL
Use reconstituted solution within the timeframe recommended by the manufacturer
Must be administered by licensed and trained healthcare professionals
8. Safety & Contraindications
Do not use in:
Patients who are pregnant or breastfeeding
Individuals with neuromuscular disorders (e.g., myasthenia gravis)
Those with known allergies to botulinum toxin or formulation ingredients
Areas with infection or active inflammation
Common side effects are mild and temporary, such as swelling, bruising, or minor muscle weakness near the injection site.